MSB 3.21% $1.13 mesoblast limited

Ann: Director Appointment/Resignation, page-6

  1. 7,423 Posts.
    lightbulb Created with Sketch. 1370
    Very nice appointment, this will further indicate to FDA that we are advancing our case and are the real deal.

    We await FDA approval................
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.